AstraZeneca stops paying for German doctors to attend conferencesBMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2949 (Published 10 May 2011) Cite this as: BMJ 2011;342:d2949
- Ned Stafford
The UK’s new Bribery Act, which took effect in April, seems to be having a knock on effect in Germany, where at least one German subsidiary of a UK based drug company has announced it will no longer pay for doctors to attend international conferences.
Kai Richter, medical director for AstraZeneca Deutschland, told the Financial Times Deutschland that beginning in the second half of the year the company will not cover the cost of hotels and travel or conference fees for doctors attending medical science events.
Dr Richter was not quoted in the article as specifically saying the decision was taken on account …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial